Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
Background The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance. This study aims to analyse the cost-effectiveness of scale-up of hepatitis C screening and treatment w...
Saved in:
| Main Authors: | Rifat Atun, Jungyeon Kim, Markus Haacker, Salmaan Keshavjee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-06-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/4/3/e001441.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic evaluation of mass screening as a strategy for hepatitis C virus elimination in South Korea
by: Hwa Young Choi, et al.
Published: (2025-03-01) -
Cost of inaction: a framework to estimate the economic cost of missing a patient with tuberculosis in the Indian context
by: Salmaan Keshavjee, et al.
Published: (2023-12-01) -
The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model.
by: James G Kahn, et al.
Published: (2014-01-01) -
Strengthening healthcare delivery with remote patient monitoring in the time of COVID-19
by: Salmaan Keshavjee, et al.
Published: (2021-03-01) -
The cost-of-illness trend of schizophrenia in South Korea from 2006 to 2016.
by: Minkyung Jo, et al.
Published: (2020-01-01)